Based on recent data, ALX Oncology Holdings Inc. (ALXO) shows an Average True Range (ATR) of 0.25 and an Enterprise Value of 808.26M. Its average trading volume over the past 3 months is 1M, indicating liquidity. These fundamental metrics provide insight into ALXO's underlying financial health and market activity.
| ATR | 0.25 |
| Enterprise Value | 808.26M |
| Avg Vol (3 Months) | 1M |
| Avg Vol (10 Days) | 732.86K |
ALX Oncology Holdings Inc. (ALXO) technical indicators as of May 5, 2026: the SMA 20 is 6.23%, SMA 50 at 39.36%, and SMA 200 at 98.51%. The RSI 14 value is 60.18, suggesting its current momentum. These technical analysis signals help assess ALXO's price trends and potential future movements.
| SMA 20 | 6.23% |
| SMA 50 | 39.36% |
| SMA 200 | 98.51% |
| RSI 14 | 60.18 |
ALX Oncology Holdings Inc. (ALXO) stock performance overview as of May 5, 2026: The 52-week high is $2.66 (currently -11.65% below), and the 52-week low is $0.404 (currently 481.68% above). Over the past year, ALXO's performance is -19.02%, compared to the S&P 500's 16.14% change.
| 52-Week High | 2.66 |
| 52-Week High Chg | -11.65% |
| 52-Week Low | 0.404 |
| 52-Week Low Chg | +481.68% |
| S&P 500 52-Week Chg | 16.14% |
According to market data, ALX Oncology Holdings Inc. (ALXO) stock's recent performance metrics show that over the last month, ALXO is -8.97%, with a Year-to-Date (YTD) performance of 16.81%. Over the past year, the stock has seen a -19.02% change. These figures summarize ALXO's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.91 | 2.05 | 2.66 | 2.66 | 2.66 | 2.66 |
| Low | 1.55 | 1.55 | 1.36 | 1.05 | 0.404 | 1.07 |
| Performance | -8.33% | -8.97% | -12.00% | +175.00% | -19.02% | +16.81% |
According to current financial data, ALXO stock's P/E (TTM) ratio is -1.02, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for ALXO, including P/S (N/A), P/B (3.98), and P/FCF (-1.22), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ALXO | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -1.02 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 3.98 | 0.2 | 8293.8 | 4.61 |
| P/FCF (TTM) | -1.22 | 254.43 | -445.49 | 31.99 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep